Technology

Who Can Benefit from BioHeal Hydrogel?

BioHeal Hydrogel is designed to address the needs of patients with chronic wounds, severe burns, and other hard-to-heal injuries. Here are some key statistics highlighting the potential beneficiaries:

• 37.3 million Americans have diabetes.
• 11.2 million diabetics are likely to develop a diabetic foot ulcer in their lifetime.
• 8.2 million Medicare patients are affected by hard-to-heal wounds each year.
• 5.2 million adults suffer from chronic wounds annually, with 60% being hard to heal.
• 1 million severe burns and abrasions occur in the US annually.

Annual Costs of Treating Chronic Wounds

• Chronic wound care costs are estimated at $28 billion annually.
• Direct costs of materials (e.g., wound dressings) account for 15-20% of total care costs.
• Treatment costs can range from $1,890 to $33,900 per episode.
• Burn treatments alone cost nearly $2 billion per year in the US.

BioHeal Matrix® Technology (BMT)

BioHeal Therapeutics focuses on bringing BioHeal Hydrogel to market, a porcine amnion-derived product processed with our patented BioHeal Matrix Technology. BioHeal Hydrogel is designed to be an easy-to-apply wound covering that supports natural healing.

What Makes BioHeal Matrix Technology Different?

Unlike other tissue processing technologies that decellularize tissue, BioHeal Matrix Technology (BMT) solubilizes the amnion membrane, transforming it into an easy-to-apply hydrogel known as BioHeal Hydrogel.

Features of BioHeal Hydrogel

• Moisture-Retaining Barrier: Provides a conducive environment for wound healing.
• Non-Immunogenic: Maintains the extracellular matrix (ECM) of the amnion, promoting natural healing.
• Research-Backed: Studies show its potential as an effective wound covering.

Hyaluronic Acid Component

BioHeal Matrix Technology combines solubilized amnion with hyaluronic acid (HA), a natural component of connective tissue. HA is predominantly made of collagen, which:

• Supports Angiogenesis and Cell Proliferation: Essential for wound healing.
• Provides a Protective Barrier: Ensures optimal healing conditions.

Committed to Innovation

BioHeal Therapeutics holds 12 global patents (issued or pending) for its Solubilized Amnion Membrane (SAM) product portfolio, covering the US, Canada, Europe, Australia, Japan, and South Korea. Initial funding included a $1,240,000 grant from the U.S. Department of Defense to develop treatment technologies for soldiers with severe burns and wounds.

Published Research

Our technology has been validated through 14 published research articles and numerous scientific presentations by the inventors and their team at WFIRM, focusing on amnion and hyaluronic acid technology platforms.

Discover the benefits of BioHeal Hydrogel and how it can impact wound care, providing effective, efficient, and innovative solutions for patients with chronic wounds and severe burns.